<?xml version="1.0" encoding="UTF-8"?>
<p>Minimum Inhibitory Concentration (MIC) assays were used to assess antibacterial activity of the isolated compounds 
 <bold>227</bold>–
 <bold>228</bold> against human pathogens (
 <italic>Escherichia coli</italic>, 
 <italic>Micrococcus luteus</italic>, and 
 <italic>Pseudomonas aeruginosa</italic>) and plant pathogen (
 <italic>Ralstonia solanacearum</italic>). Chloromycetin was used as a positive antibacterial control. Notably, compound 
 <bold>227</bold> demonstrated potent activity against 
 <italic>P. aeruginosa</italic> with an MIC value of 1 μg/mL, which was better than that of the positive control chloromycetin (MIC = 4 μg/mL). Compound 
 <bold>228</bold> displayed activity against 
 <italic>Micrococcus luteus</italic> and 
 <italic>Pseudomonas aeruginosa</italic> with the same MIC value of 8 μg/mL (2 μg/mL and 4 μg/mL against 
 <italic>Micrococcus luteus</italic> and 
 <italic>Pseudomonas aeruginosa</italic> for Chloromycetin). In contrary to compounds 
 <bold>228</bold> and the known compound 
 <bold>A</bold> (
 <xref ref-type="fig" rid="ijms-22-00959-f013">Figure 13</xref>), 
 <bold>B</bold> (
 <xref ref-type="fig" rid="ijms-22-00959-f013">Figure 13</xref>) showed stronger antibacterial activity (MIC values of 4, 4, 8, and 8 μg/mL against 
 <italic>E. coli</italic>, 
 <italic>M. luteus</italic>, 
 <italic>P. aeruginosa</italic>, and 
 <italic>R. solanacearum</italic>, respectively), indicating that hydroxylation at C-10 can augment antibacterial activity [
 <xref rid="B74-ijms-22-00959" ref-type="bibr">74</xref>].
</p>
